| Identification | Back Directory | [Name]
Dibenzo[a,g]quinolizinium, 5,6-dihydro-3,9-dimethoxy-, chloride (1:1) | [CAS]
2367641-24-3 | [Synonyms]
Dibenzo[a,g]quinolizinium, 5,6-dihydro-3,9-dimethoxy-, chloride (1:1) | [Molecular Formula]
C19H18ClNO2 | [MOL File]
2367641-24-3.mol | [Molecular Weight]
327.81 |
| Hazard Information | Back Directory | [Description]
NBD-125, a berberine analogue, is an RXRα activator. | [Uses]
NBD-125 (B-12), a berberine analogue, is an RXRα activator, with an IC50 of 31.10 μM in KM12C cell[1]. | [References]
[1] Beibei Xu, et al. Structure-Activity Relationship Study Enables the Discovery of a Novel Berberine Analogue as the RXRα Activator to Inhibit Colon Cancer. J Med Chem. 2020 Jun 11;63(11):5841-5855. DOI:10.1021/acs.jmedchem.0c00088 |
|
|